Do lung cancer patients need molecular profiling?

Molecular profiling can offer some lung cancer patients a personalized treatment approach that's often more effective than chemotherapy.

Plasma-first: accelerating lung cancer diagnosis and molecular ...

Molecular profiling of tumor tissue is the gold standard for treatment decision-making in advanced non-small cell lung cancer (NSCLC).

Lung cancer experts use molecular markers to optimize patients ...

Nowadays, Mirshahidi says experts can treat patients with various targeted therapies based on eight "actionable" molecular markers in lung ...

Deciphering the Molecular Profile of Lung Cancer: New Strategies ...

Recent advances in radiological imaging and genomic analysis are profoundly changing the way to manage lung cancer patients.

Molecular profiling in lung cancer | memo - Magazine of European ...

Thus, broad molecular profiling displays a standard-of-care approach particularly in patients with advanced adenocarcinoma at the time of the ...

Molecular profiling across histologies in lung cancer: Time to ...

Biomarker testing is recommended in lung adenocarcinoma (LUAD), while in tumors with other histologies it is reserved when clinical features ...

Case report: Molecular profiling facilitates the diagnosis of ... - Frontiers

In challenging cases, morphology-based traditional pathology methods have important limitations, while molecular profiling can provide valuable ...

Molecular profiling and feasibility using a comprehensive hybrid ...

Targeted next-generation sequencing (NGS) is recommended to screen actionable genomic alterations (GAs) in patients with non-small-cell lung ...

The Value of Comprehensive Molecular Profiling in Early Stage ...

Comprehensive molecular profiling, which typically covers several hundred genes to provide a thorough interrogation of the tumor mutational landscape including ...

Molecular Profiling Continues to Shape the Future of Cancer Care

In the diagnosis of lung cancers, molecular profiling has allowed clinicians to view entities like non-small cell lung cancer (NSCLC) as ...

Overcoming Barriers to Molecular Profiling in NSCLC Management

For health care providers treating non–small cell lung cancer, there are a number of barriers to complete comprehensive molecular profiling. One ...

Molecular testing strategies in non-small cell lung cancer: optimizing ...

A recent IASLC statement paper recommends that liquid biopsy can be considered at the time of initial diagnosis in all patients with advanced NSCLC who need ...

Why do you need molecular profiling if we can just take the tumor out?

EGFR is a common mutation in lung cancer, and we now have drugs called EGFR tyrosine kinase inhibitors that work quite well for patients with that particular ...

Molecular profiling for precision cancer therapies | Genome Medicine

Cancer precision medicine is defined as “the use of therapeutics that are expected to confer benefit to a subset of patients whose cancer ...

Optimizing the Use of Molecular Profiling in Non–Small Cell Lung ...

Current guidelines state that molecular testing should be conducted at the time of initial diagnosis as well as tumor progression on targeted ...

Comprehensive molecular profiling of lung adenocarcinoma - Nature

Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report molecular profiling of 230 resected lung ...

Practice-Level Variation in Molecular Testing and Use of Targeted ...

Targeted therapies have substantially improved outcomes for some patients with non–small cell lung cancer (NSCLC) and colorectal cancer (CRC).

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling ...

Comprehensive molecular profiling (CMP) plays an essential role in clinical decision making in metastatic non–small-cell lung cancer ...

Molecular profiling and feasibility using a comprehensive hybrid ...

Targeted next-generation sequencing (NGS) is recommended to screen actionable genomic alterations (GAs) in patients with non-small-cell lung cancer (NSCLC). We ...

Genomic Profiling of Advanced Non–Small Cell Lung Cancer in ...

National guidelines have advocated broad molecular profiling as a part of the standard diagnostic evaluation for advanced non–small cell lung cancer (NSCLC) ...